A null mutation was prepared in the mouse for CD18, the beta2 subunit of leukocyte integrins. Homozygous CD18 null mice develop chronic dermatitis with extensive facial and submandibular erosions. The phenotype includes elevated neutrophil counts, increased immunoglobulin levels, lymphadenopathy, splenomegaly, and abundant plasma cells in skin, lymph nodes, gut, and kidney. Very few neutrophils were found in spontaneously occurring skin lesions or with an induced toxic dermatitis. Intravital microscopy in CD18 null mice revealed a lack of firm neutrophil attachment to venules in the cremaster muscle in response to N-formyl- methionyl-leucyl-phenylalanine. A severe defect in T cell proliferation was found in the CD18 null mice when T cell receptors were stimulated either by staphylococcal enterotoxin A or by major histocompatibility complex alloantigens demonstrating a greater role of CD11/CD18 integrins in T cell responses than previously documented. The null mice are useful for delineating the functions of CD18 in vivo.
A null mutation was prepared in the mouse for CD18, the beta2 subunit of leukocyte integrins. Homozygous CD18 null mice develop chronic dermatitis with extensive facial and submandibular erosions. The phenotype includes elevated neutrophil counts, increased immunoglobulin levels, lymphadenopathy, splenomegaly, and abundant plasma cells in skin, lymph nodes, gut, and kidney. Very few neutrophils were found in spontaneously occurring skin lesions or with an induced toxic dermatitis. Intravital microscopy in CD18 null mice revealed a lack of firm neutrophil attachment to venules in the cremaster muscle in response to N-formyl- methionyl-leucyl-phenylalanine. A severe defect in T cell proliferation was found in the CD18 null mice when T cell receptors were stimulated either by staphylococcal enterotoxin A or by major histocompatibility complex alloantigens demonstrating a greater role of CD11/CD18 integrins in T cell responses than previously documented. The null mice are useful for delineating the functions of CD18 in vivo.
Leukocyte integrins play a major role in cell–cell and
cell–matrix interactions (1, 2). The β2 integrins include
LFA-1, macrophage antigen-1 (Mac-1),1 p150,95, and possibly a fourth form (3); each functions as heterodimeric
molecules, with a separate α chain (CD11a, b, c, or d) and
a common β chain (CD18). These leukocyte receptors are
of importance in adhesion and signaling in a variety of
physiological and pathological conditions.Substantial information is available regarding the complex cellular function of CD18 based on studies using
blocking antibodies and on analysis of genetic deficiencies
in humans and in cattle (4–7). The human disorder is
known as leukocyte adhesion deficiency type I (LAD I),
and is caused by heterogeneous mutations in CD18. CD18-deficient patients suffer from recurrent microbial infections,
leukocytosis, impaired wound healing, and lack of pus formation. A hypomorphic mutation in CD18 was generated
in mice earlier by gene targeting, and homozygotes displayed 2–16% of normal levels of CD18 on leukocytes (8).
This hypomorphic CD18-deficient mouse does not show
spontaneous infections as occur in LAD I patients; however, when this mutation was backcrossed onto PL/J inbred strain, homozygous mice developed a dermatitis resembling humanpsoriasis (9). Although the hypomorphic
mutation is valuable for assessing the effect of reduced expression of β2 integrins in chronic inflammatory processes,
it is less valuable for functional evaluation of the role of
CD18, since animals are not completely deficient for
CD18. HumanCD18 deficiency includes a range of severity that overlaps the phenotypes seen with the mouse hypomorphic and null mutations, with many severely affected
and some mildly affected patients (7).We report here the characterization of mice completely
deficient in CD18 that were generated by homologous recombination in embryonic stem (ES) cells. In contrast to
CD18 hypomorphic mutant mice (8), CD11a-deficientmice (10), and CD11b-deficient mice (11, 12), the CD18
null mice reveal a phenotype closely resembling LAD I patients, including spontaneous occurrence of mucocutaneous infections. These CD18 null mice provide the first murine model of severe human LAD I and reveal a prominent
requirement for CD18 integrins in T cell activation by staphylococcal enterotoxin A or by MHC alloantigens.
Materials and Methods
Targeting Construct and Generation of Mutant Mice.
We have used
a previously published (8) targeting construct with a ∼10-kb segment of the CD18 gene containing exon 2 and 3 and a neomycin-resistance gene (neo) cassette with a short version of the
RNA polymerase II promoter and the bovine growth hormone
polyadenylation signal; the neomycin cassette thus, disrupts the
splice-acceptor site of exon 3 (8). The AB1 ES cell line was electroporated (13) with the construct after digestion with KpnI for
use as a replacement vector. Digestion with HindIII was used to
identify homologous recombinants on Southern blots hybridized
with the 3′ flanking probe as indicated (Fig. 1
A). The mutation
resulted in a ∼6.5-kb HindIII fragment compared with a 5.0-kb
HindIII fragment for the wild-type genomic DNA. Embryonic
stem cells confirmed by Southern blotting to carry the replacement mutation were used for germline transmission which was
confirmed by Southern blot analysis of tail DNA using HindIII
digestion and the 3′ flanking probe. Progeny containing the mutant CD18 allele were intercrossed resulting in CD18 homozygous mutant pups. The results presented are from mice of mixed
129/Sv and C57BL/6J background. For all experiments, homozygous progeny and wild-type littermates from heterozygous
intercrosses were used. Sentinel mice housed in the same rooms
at the barrier facility as the CD18 null mice repeatedly tested negative for common viruses.
Figure 1
Preparation and analysis of the CD18 null mutation. A shows the genomic region to be targeted above with the targeted mutation below.
DNA length is drawn to scale and the first three exons are indicated as solid rectangles. The location of the 3′ and 5′ flanking probes are shown as hatched
boxes. Restriction enzyme sites are indicated as follows: E, EcoRI; H, HindIII; K, KpnI; and P, Pst. The targeting vector was linearized with KpnI, and
a replacement mutation was obtained with insertion of a neomycin cassette at a PstI site that occurs precisely at the boundary of the intron and the 5′ end
of exon 3. B shows a Southern blot with the 3′ flanking probe and genomic DNA isolated from the tails of wild-type (+/+), homozygous CD18 null (−/−),
and heterozygous (+/−) mice. C presents the analysis of expression of CD18 on the surface of leukocytes from wild-type and homozygous CD18 null
mice. FACS® analysis was performed as described in Materials and Methods. An isotype-matched control antibody was used (top). Expression of CD18
was quantitated by immunostaining with FITC-conjugated mAb C71/16.
Histopathology.
A total of 33 animals were examined representing three age groups, both sexes, and both homozygous and
wild-type mice. Affected and control mice were killed for histological analysis and 32 different tissues were fixed in 10% (vol/
vol) neutral buffered formalin supplemented with zinc chloride.
Paraffin-embedded sections were stained with hematoxylin-eosin.
Peripheral White Blood Cell Counts.
Mice were bled from the
retroorbital sinus into EDTA-anticoagulated tubes while under
anesthesia. Total white blood cell counts and differential leukocyte counts were determined using a Technicon H.1 analyzer (Miles
Diagnostics, Elkhart, IN) calibrated for analysis of murine samples. Blood smears were prepared with Wright's stain.
Microbiological Analyses.
For bacterial culture, sterile swabs
were moistened in phosphate-buffered saline containing 0.1%
Triton X-100 and used to scrub the area for inoculation onto
Columbia sheep blood agar plates. Swabs were also inoculated
onto Mycosel agar and incubated at 25°C for 1 mo for the culture
of fungi. Swabs also were inoculated on Löwenstein Jensen's agar
and incubated at 30°C for 2 mo for isolation of mycobacteria.
Susceptibility to Streptoccus pneumoniae Infection.
Wild-type and
CD18 null mice aged 8 wk were inoculated intraperitoneally
with a single 0.1-ml dose (6–8 × 106 CFU/ml) of S. pneumoniae
as described in detail elsewhere (14). Blood (10 μl) was obtained
by nicking the tail vein using sterile technique for culture by inoculation on blood agar incubated at 35°C. The degree of bacteremia was characterized by the number of CFU on the blood culture plate. Statistical analyses were performed using Kaplan Meier
and log rank analysis for bacterial load, presence or absence of
bacteremia, and mortality.
Cell Staining and Flow Cytometry.
Peripheral blood was collected from homozygous mutants or littermate controls from the
retroorbital sinus with EDTA anticoagulation. Expression of
CD18 was determined by immunostaining with a fluorescein
isothiocyanate-conjugated anti-CD18 mAb (C71/16; PharMingen,
San Diego, CA). Also, 4 × 105 fresh splenocytes or thymocytes
were stained with 1 μg of FITC-conjugated and/ or PE-conjugated CD3, CD4, and CD8-specific or isotype control antibodies
for 20–30 min on ice and fixed with 1% paraformaldehyde. Cell
surface phenotype was determined by immunofluorescent analysis
with an EPICS Profile flow cytometer (Coulter Immunology,
Hialeah, FL).
Toxic Dermatitis.
Six sex-matched mutant and wild-type animals were used at 7– 9 wk of age. The irritant response was initiated by applying 10 μl of 2% (vol/vol) dinitrofluorobenzene
(DNFB; Sigma Chemical Co., St. Louis, MO) in olive oil to the
dorsal and ventral aspects of the right ear. The resulting inflammatory response was monitored by microscopic examination at 5 h
after DNFB application.
Intravital Microscopy.
Three CD18 null mice and three wild-type littermate controls were anesthetized with an i.p. injection of
ketamine hydrochloride (100 mg/kg, Ketalar; Parke-Davis, Morris
Plains, NY) after premedication with sodium pentobarbital (30
mg/kg, Nembutal; Abbott Laboratories, Chicago, IL,) and atropine (0.1 mg/kg, Elkins-Sinu, Cherry Hill, NJ) i.p. The trachea,
left jugular vein, and left carotid artery were cannulated to facilitate respiration and allow injection of anesthetic, measurement of
blood pressure, and blood sampling. Blood pressure was monitored continuously (model BPMT-2; Stemtech, Inc., South Natick, MA) and carotid blood samples were drawn at the beginning
and end of the observation period. Mice were thermocontrolled
using a small animal heating pad (model 50-7503; Harvard Apparatus, Inc., South Natick, MA) and received anesthetic as required
to maintain blood pressure in the range 60–100 mm of Hg.The cremaster muscle was prepared for intravital microscopy as
described (15). During surgery (typically 10 min) and data collection, the cremaster was superfused with thermocontrolled (37°C)
bicarbonate-buffer (132 mM NaCl, 4.7 mM KCl, 2 mM CaCl2,
1.2 mM MgCl2, and 18 mM NaHCO3 equilibrated with 5%
CO2 in N2 to adjust pH to 7.35).Microscopic observations were made up to 1 h after exteriorization of the cremaster using a (Carl Zeiss Inc., Thornwood,
NY) intravital microscope with a saline immersion objective
(SW40.0.75 numerical aperture). Venules with diameters between 20 and 40 μm were observed and recorded through a
CCD camera system (model VE-1000CD; Dage-MTI, Inc.,
Michigan City, IN).Glass micropipettes were drawn from standard borosilicate
glass (outer diameter 1.0 mm; Stoelting, Wood Dale, IL) on a
vertical micropipette puller (Stoelting) and beveled to a tip diameter of 7–10 μm using a micropipette grinder (model EG-40;
Narishige, Sea Cliff, NY) with 0.3 μm abrasive foil (no. 6775;
A.H. Thomas, Philadelphia, PA). The pipettes were filled with
∼15 μl of filtered (0.45 μm, Millex HV4; Millipore Corp., Bedford, MA) 10 μM fMLP (Sigma Chemical Co.) solution. An air-tubing and syringe system attached to the pipette holder served as
a pressure reservoir controlled by a 10-ml syringe and allowed
continuous, stable microinfusions. Venules were selected for injection on the basis of size (20–40 μm) and presence of baseline
rolling with little or no firm adhesion of cells; these venules were
recorded for 60 s before placement of the pipette. A pipette was
placed in proximity (within 40 μm) to the observed vessel using a
piezo-driven micromanipulator (model DC-3K; Märzhäuser-Wetzlar, Upper Saddle River, NJ) with the beveled tip penetrating the
interstitial tissue. The vessel was recorded for 60 s in the presence
of the pipette tip without infusion. No difference was seen between the number of firmly adhered cells before and after pipette
placement (data not shown). Microinfusion of 10 μM fMLP which
caused a slight swelling of the impaled interstitial tissue, was initiated by application of pressure to the air-tubing system and was
maintained for 60 s. The vessel was recorded for a further 60 s after termination of microinfusion.The number of firmly adhered leukocytes in the observed vessel was counted off-line at four time points; (a) after 60 s recording, (b) after 60 s + pipette, (c) after 60 s fMLP infusion, and (d)
60 s after termination of fMLP. Length and diameter of the observed vessel was measured using a commercial digital image processing system (Macintosh 7100 computer video capture board
Scion Corporation, Frederick, MD). Results are presented as
number of firmly adhered cells/100 μm of vessel length. Rolling
leukocyte fluxes were also determined for the four observation
periods by counting the number of leukocytes distinguishable
from the blood stream passing a line perpendicular to the vessel
axis. For this purpose, the video tapes were replayed at one half to
one-fifth original speed. Counting visibly distinguishable cells is
widely used for analysis of leukocyte rolling and is known to be
accurate at blood flow velocities above 0.5 mm/s (16). Vessels
with flow velocities below 0.5 mm/s were not studied as it is difficult to distinguish rolling cells from free flowing cells at lower
flow rates. Total leukocyte flux through a given venule was estimated as a product of systemic leukocyte count and volumetric
flow rate of blood through the venule (calculated using microvessel diameter and mean blood flow velocity assuming cylindrical
geometry). Leukocyte rolling flux fraction is defined as the flux of
rolling leukocytes as a percentage of total leukocyte flux and is
thus independent of variation in systemic leukocyte counts.
In Vitro Adherence Assay for Neutrophils.
Neutrophils from mutant mice and wild-type littermates were isolated from bone marrow as described (12). A visual adherence assay was used for
quantitating adhesion of murine neutrophils to KLH-coated glass,
a surface to which neutrophils adhered only after stimulation (17).
Briefly, neutrophils were preincubated at 37°C for 10 min and
exposed to zymosan activated serum (ZAS) for an additional 10
min in the presence or absence of a saturating level of antibody (5
μg/ml) before injection into the adherence chambers. Cells were
allowed to settle for 500 s and inverted for 500 s; the percent adherence was determined by counting 5–10 high power fields per
experimental condition.
Assays of Luminal-enhanced Chemiluminescence.
The evolution
of light from neutrophils undergoing iC3b-mediated phagocytosis after activation by opsonized zymosan particles was quantitated
as described previously (18). Zymosan particles (ICN Pharmaceuticals, Irvine, CA) were opsonized in freshly obtained serum from
healthy mice for 45 min at 37°C. Opsonized zymosan particles
were then washed three times and resuspended in PBS to a final
concentration of 0.5 mg/ml. Phagocytotic reaction mixtures contained 106 neutrophils with 10−8 M luminal. Chemiluminescence
was quantitated after the addition of PBS or 0.5 μg/ml of opsonized zymosan particles to reaction mixture.
T Cell Proliferation Upon Stimulation with SEA or Mixed Lymphocyte Reaction.
Splenocytes were treated with low ionic strength
media and Tris ammonium chloride to remove dead cells and red
blood cells, respectively (19). 4 × 105 cells/well were plated in
96-well round bottom microtiter plates in a total volume of 200 μl
in supplemented Dulbecco's Modified Eagle's medium (sDME)
with 10% FCS (19). The cells were cultured alone or with SEA at
0.1 ng/ml to 20 μg/ml (Toxin Technology, Sarasota, FL) for 96 h
and labeled with [3H]thymidine (DuPont-NEN, Boston, MA)
for the last 5–6 h. They were processed for liquid scintillation
counting (Betaplate, Wallace, Gaithersburg, MD) and the resulting data expressed as mean cpm ± SEM of triplicate cultures.CD18 null and wild-type splenocytes (4 × 105 cells/well)
were also stimulated in the MLR by increasing concentrations of
allogeneic BALB/c (H-2d) or syngeneic CD18 null or wild-type
control (H-2b) spleen cells that had been irradiated to 1,500 rads.
MLR were labeled and harvested as above after 96 h culture in
10% sDME with 10 μM 2-mercaptoethanol (Sigma Chemical
Co.), in round bottom microtiter plates. CD18 null and wild-type splenocytes were also stimulated with ionomycin (200 ng/ml)
and phorbol 12-myristate 13-acetate (1 ng/ml; Sigma Chemical
Co.), and were labeled and harvested at 24-h intervals through
120 h of culture.
Determination of Immunoglobulin and Cytokine Levels.
Serum immunoglobulin isotypes were determined by sandwich ELISA as
previously described (20). Bioassays for IL-3, GM-CSF, and IL-6
were performed as described previously (21, 22).
Results
Generation of a CD18 Null Mutation in Mice.
To introduce
a null mutation into the CD18 locus, a previously reported
targeting construct (8) that was used to introduce a duplication resulting in a hypomorphic allele was now used to
produce a replacement mutation (Fig. 1
A). The construct
contains the neomycin-resistance cassette disrupting the 5′
boundary of exon 3, thus preventing any synthesis of normal CD18 protein. Using Southern analysis, recombinant
colonies were found with a frequency of 1 in 125 among
the G418-resistant clones. The mutation was transmitted to
the germline, and heterozygous mutant mice were intercrossed. Homozygous mutant (hereafter referred to as CD18
null) mice were detected by Southern blotting (Fig. 1
B) at
3 wk of age at a lower than expected frequency ranging
from 12 to 18% of 102 progeny tested over different intervals. However, when performing Southern blot analysis of
18-d-old embryos, an expected frequency of 25% was obtained, suggesting that some CD18 null offspring die perinatally. As a quantitative assessment of cell surface expression
of CD18, FACS® analysis of leukocytes was performed
(Fig. 1
C). Surface expression of CD18 was found on leukocytes from wild-type animals, but there was no detectable expression of CD18 on leukocytes from CD18 null mice.The function of CD18 was assessed by measuring the
ability of neutrophils to attach to KLH-coated glass and to
generate an oxidative burst after exposure to chemoattractants; this method reveals a severe deficit in CD18-deficient
human cells (17). There was almost no adhesion of neutrophils from wild-type or CD18 null mice without stimulation, but exposure of neutrophils to zymosan activated serum, which is rich in C5a, resulted in a substantial increase
in adhesion of neutrophils derived from wild-type mice
(Fig. 2
A). By contrast, no significant neutrophil adhesion
was observed with cells from CD18 null mice. Neutrophil
adhesion of wild-type mice was substantially abrogated by
blocking antibodies against CD11b, whereas blocking antibodies against CD11a and an isotype-matched rat IgG did
not affect neutrophil binding to KLH (Fig. 2
A). Similar
results were obtained for phagocytosis associated oxidative
burst that earlier had been shown to be Mac-1 (CD11b/
CD18) dependent (23). The evolution of light by neutrophils in association with iC3b mediated phagocytosis was
quantitated by a luminal-enhanced chemiluminescence assay (23). Neutrophils isolated from wild-type mice exhibited substantial chemiluminescence when mixed with opsonized zymosan particles, whereas neutrophils from CD18
null mice did not exhibit significant activity (Fig. 2
B). The
absence of surface expression of CD18, the lack of neutrophil adhesion, and the deficiency of oxidative burst are
consistent with the complete disruption of the CD18 molecule.
Figure 2
Analysis of neutrophil adherence and respiratory
burst in wild-type and CD18
null mice. In A, adherence of
murine neutrophils to a KLH-coated glass surface was measured as described in Materials
and Methods. Isolated neutrophils were incubated with PBS
or mAb for 30 min at room temperature: 10 μg/ml Ml/70 (anti-CD11b), 10 μg/ml KBA (anti-CD11a), or 10 μg/ml SFDR5
(Ig-matched control Ab). ZAS
was added immediately before
injecting the cell mixture into
the adhesion chamber. Data are
presented as mean ± SEM (n =
3); P <0.01 for wild-type (solid
bars) versus CD18 null (open bars) in absence of antibodies. B depicts chemiluminescence of neutrophils from wild-type and CD18 null mice. Isolated
neutrophils were mixed with 10−8 M luminal before the addition of PBS or 0.5 μg/ml of freshly opsonized zymosan particles (OpZ ). Result represents
mean ± SEM (n = 3); P <0.01 for wild-type versus CD18 null with OpZ.
The Phenotype of Homozygous CD18 Null Mice Resembles
Human LAD I.
At various times in managing the mouse
colony, 10–40% of the newborn CD18 null animals died
perinatally. The surviving CD18 mutant mice developed
progressive perioral soft tissue swelling, facial alopecia, reddening of the skin, and extended facial and submandibular
ulcerative dermatitis at ∼3 mo of age (Fig. 3, A and B).
This phenotype was observed in 95% (48 of 51) of mice on
a mixed 129/Sv and C57BL/6J background.
Figure 3
Gross morphology and histology of CD18 null mice. A demonstrates alopecia in the neck and upper thorax with severe ulcerative dermatitis
and perioral soft tissue swelling. B shows extended facial alopecia and erosions with conjunctivitis of the eye. C demonstrates ulcerative dermatitis with
full thickness necrosis of the epidermis covered by an eosinophilic crust with entrapped inflammatory cells and bacterial colonies (arrows). There is adjacent epidermal hyperplasia. The dermal inflammatory infiltrate consists of lymphocytes, histiocytes, mast cells, occasional plasma cells, and few neutrophils. E, epidermis; D, dermis; and U, ulceration. Original magnification 250×. The spleen is shown in D with hyperplasia of the red pulp, multiple
plasma cells (*), and occasional Russell bodies (arrows), the latter indicative of abnormal deposition of immunoglobulins within plasma cells. Original magnification 400×.
Histopathology of the skin revealed superficial erosions
and ulcerations covered by an eosinophilic crust with entrapped necrotic inflammatory cells and bacterial colonies
(Fig. 3
C). The dermis beneath and adjacent to the erosions
revealed a predominantly mononuclear inflammatory cell
infiltrate consisting of lymphocytes, histiocytes, and occasional perivascular plasma cells with far fewer neutrophils
than would be expected in a wild-type animal at a site of
bacterial infection, suggesting that neutrophil extravasation
into the interstitial tissue is severely impaired (Fig. 3
C).
Affected mice also displayed splenomegaly with a 2.5-fold
increase in weight (data not shown) due to a myeloid hyperplasia within the red pulp; similar hyperplasia was
present in the bone marrow of CD18 null mice. Occasional inflammatory lesions were noted in mutant mice in
heart, salivary gland, liver, and intestine. No consistent pattern was noted, and these lesions were usually associated with
concurrent cutaneous disease. In addition, a reactive lymphadenopathy predominantly involving nodes that drain the
anatomical sites of skin erosions was observed. The major
histological abnormality in these nodes was an accumulation of plasma cells, some revealing periodic acid-Schiff
(PAS)-positive inclusions (Russell bodies) indicative of increased immunoglobulin deposition. At 2.5–3 mo of age,
serum total IgG, IgG1, IgG2a, and IgG2b were increased
10–15-fold in CD18 null mice compared with wild-type
littermates (Table 1). CD18 null mice showed significant
but more modest increases in IgG3, IgM, and IgA. Plasma
cell infiltration with Russell body formation was also observed in spleen (Fig. 3
D), kidney, small intestine, iliac
lymph nodes, and the dermis and subcutaneous tissue of the
skin from the dorsum of the head, shoulders, and the dorsum of the neck. Numbers of circulating leukocytes in
CD18 null mice were increased up to sixfold compared
with littermates (Table 2).
Table 1
Ig Concentrations in the Sera of Wild-type and CD18
Null Mice
Ig Class
Mean ± SD
Wild-type (n = 6)
CD18 null (n = 6)
μg/ml
IgG total
705 ± 312
18,162 ± 9,049
IgG1
243 ± 164
4,568 ± 2,769
IgG2a
486 ± 440
5,322 ± 6,293
IgG2b
81 ± 42
1,380 ± 834
IgG3
234 ± 45
397 ± 104
IgM
116 ± 6
242 ± 66
IgA
1,463 ± 149
2,310 ± 448
IgE
162 ± 197
335 ± 223
Table 2
Leukocyte Counts in CD18 Null and Wild-type Mice
Cells
Mean ± SD
Wild-type (n = 6)
CD18 null (n = 4)
× 103/μl
Leukocytes
7.9 ± 3.1
43.9 ± 8.2
Neutrophils
2.2 ± 1.5
24.0 ± 10.4
Lymphocytes
5.2 ± 3.1
18.0 ± 2.8
Monocytes
0.23 ± 0.08
0.87 ± 0.16
Eosinophils
0.14 ± 0.07
0.49 ± 0.17
Basophils
0.04 ± 0.02
0.15 ± 0.02
Increased circulating leukocyte counts were largely due
to elevated numbers of circulating neutrophils, but lymphocyte and monocyte numbers were also increased. The
neutrophils revealed hypersegmentation and appendix formation of the nuclei. Since IL-3 and GM-CSF have been
shown to stimulate granulopoesis (21) and IL-6 to prevent
apoptosis (24) and thus contribute to elevation of peripheral neutrophil counts, serum levels of these cytokines were
studied by specific bioassays in mice >10 wk of age. Serum
levels of IL-3 and IL-6 but not GM-CSF were ≥20-fold
elevated in CD18 null mice; values for CD18 null versus
wild-type mice, respectively, were as follows: IL-3 mean
279 pg/ml (range 60–550; n = 4) versus mean 52 pg/ml
(range 30–160; n = 4) and IL-6 mean 715 pg/ml (range
562–1258, n = 6) versus mean 42 pg/ml (range <25–68, n =
6). Phenotyping of CD4, CD8, and CD3 was performed
on T cells from spleen and thymus using FACS® analysis
(not shown), and no significant differences were found between CD18 null and wild-type mice indicating that
CD18 is not essential for T cell development.Since LAD I patients have been reported to suffer from
bacterial infection, and because of observed perioral and
conjunctival lesions, oral and conjunctival cultures were
obtained from 12 CD18 null and 4 wild-type mice. All 16
oral cultures reflected the coprophagic behavior of mice
with various fecal contaminants. One of the four wild-type
conjunctival cultures was positive for Staphylococcus xylosus,
and the other three cultures were negative. All 12 conjunctival cultures from the CD18 null mice were positive with
one to three organisms of commensal or fecal origin including Escherichia coli, Lactobacillus species, Enterococcus faecalis, Proteus mirabilis, Streptococcus, and Staphylococcus epidermidis. The number of organisms increased with the severity of
conjunctivitis noted clinically. None of the fungal cultures
from six CD18 null and six wild-type mice showed any
growth. Conventional hematoxylin-eosin and Gram staining occasionally detected bacterial colonies on the crust of
erosions, but bacteria were not detected invading the tissue
beneath. Acid fast, PAS, and Grocott staining of skin sections failed to detect organisms below the surface.
Increased Mortality in CD18-deficient Mice Inoculated with S.
pneumoniae.
Wild-type mice and CD18 null mice aged 8
wk were inoculated intraperitoneally with 6–8 × 106 CFU
of S. pneumoniae. There was a 53% survival by day 10 in
wild-type mice compared with no survival of CD18mice
(P = 0.003; Fig. 4). In wild-type mice, survivors cleared
bacteremia so that all animals were either dead or free of
bacteremia by day 10. In contrast, almost all blood cultures
were positive in CD18 null mice until death. CD18 null
mice consistently had a higher mean number of bacterial
colony forming units/10 μl in their blood cultures at various times after inoculation with S. pneumoniae (167 ± 145
at 24 h, 181 ± 139 at 48 h, 177 ± 126 at 72 h, 159 ± 137
at 96 h, 157 ± 142 at 120 h, 52 ± 84 at 144 h, and 35 ±
99 at 192 h) compared with wild-type mice (134 ± 133 at
24 h, 58 ± 99 at 48 h, 61 ± 118 at 72 h, 24 ± 68 at 96 h,
2.3 ± 8.2 at 120 h, 9.0 ± 30 at 144 h, and 0.0 ± 192 h;
mean ± SD); P value by log rank analysis <0.0001. The
baseline leukocyte and neutrophil counts in the blood of
CD18 null mice were approximately four times those of
wild-type in these studies (compare to Table 1). In both
groups, the leukocyte counts dropped substantially in the
first 24 h after S. pneumoniae inoculation (54% decrease in
controls, 66% decrease in CD18mice) and then increased
gradually. The neutrophil counts in the peritoneal fluid 48 h
after intraperitoneal inoculation of S. pneumoniae, though
not significant, were slightly increased in CD18 null mice
compared with wild-type indicating that significant numbers of neutrophils can emigrate in the complete absence of
CD18. Thus, CD18 null mice demonstrated a marked increase in susceptibility to death from bacteremia after inoculation with S. pneumoniae.
Figure 4
Increased bacteremia and mortality in CD18 null mice inoculated with S. pneumoniae. Mice were injected intraperitoneally with S.
pneumoniae as described in Materials and Methods. Significant increased
mortality (P = 0.0003; solid bars) and increased bacteremia (hatched bars) in
surviving mice (P = <0.0001) were found for CD18 null mice.
Neutrophil Emigration Is impaired in Toxic Dermatitis.
As reported earlier for bovine and human LAD (25–27), we detected extremely low numbers of neutrophils in the interstitial connective tissue beneath the spontaneously occurring
skin erosions in CD18 null mice (Fig. 3
C). To study neutrophil extravasation in a more controlled fashion, we induced a toxic dermatitis by applying 2% DNFB onto the
ear of mice and studied neutrophil extravasation at 5 h after
application of the irritant. A severe toxic response was observed both in CD18 null mice and in littermate controls
with spongiosis of the epidermis and edema formation
within the dermis. However, although many neutrophils
were detected in the interstitial connective tissue in wild-type mice (Fig. 5
A), virtually no neutrophils were seen
within the dermis of CD18 null mice (Fig. 5
B). In CD18
null mice, neutrophils were seen within the lumen of dermal vessels.
Figure 5
Neutrophil response
to toxic dermatitis. Ears were
challenged with topical application of 10 μl 2% DNFB 5 h before death. The dense neutrophil
infiltrate in a wild-type mouse is
shown in A and the lack of neutrophil response despite the presence of edematous interstitial tissue is shown in a CD18 null
mouse in B. Hematoxylin and
eosin staining at an original magnification of 400× is shown.
Dermis (d) and cartilage (c) are
labeled.
Intravital Microscopy Reveals Reduction of Firm Adhesion in
Venules.
To elucidate the mechanism underlying the lack
of neutrophil extravasation, intravital microscopy was performed. Firm cell attachment to the endothelial lining of
the studied vessels did not occur in wild-type or CD18 null
mice without stimulation by N-formyl-methionyl-leucyl-phenylalanine (fMLP; Fig. 6, A and B). Microinjection of
fMLP resulted in a large increase in firm cell adherence in
wild-type mice (Fig. 6, C and E), but no increase was observed in CD18 null mice upon fMLP stimulation (Fig. 6,
D and E). Spontaneous rolling of cells occurred both in
wild-type and in CD18 null mice, though in CD18 null to
a significantly greater extent, most likely reflecting the dramatic increase in the peripheral leukocyte numbers (Fig. 6
F). Although rolling was significantly reduced in wild-type
mice upon fMLP stimulation reflecting induction of firm
adhesion, no significant decrease in the number of rolling
cells was detected in CD18 null mice upon fMLP stimulation. The intravital microscopy and analysis of toxic dermatitis indicate that CD18 is required for leukocyte adhesion
and emigration in these settings.
Figure 6
Firm attachment and rolling of leukocytes is altered in CD18
null mice. Intravital microscopy was performed as described in Materials
and Methods. Venules with diameters between 20 and 40 μm were observed and recorded through a CCD camera. Almost no firm attachment
of leukocyte occurred in a wild-type mouse before fMLP infusion (A).
Infusion of fMLP resulted in a substantial increase in firmly attached leukocytes in a wild-type mouse (C ). No firm attachment of leukocytes to
the endothelial lining was observed in CD18 null mice before or after
fMLP stimulation (B and D, respectively). The number of firmly adherent
leukocytes in the observed vessels was quantitated before fMLP infusion
and 1 min after infusion (E). Results are presented as number of firmly
adherent cells/100 μm of vessel length. Rolling leukocyte fluxes were determined before fMLP infusion and 1 min after infusion (F ). Results
(mean ± SEM, n = 3) are expressed as the flux of rolling leukocytes per
minute.
CD18 Plays a Major Role in TCR-dependent T Cell Proliferation.
We evaluated the importance of CD18 in T cell
activation when the TCR was stimulated in the MLR or
with staphylococcal enterotoxin A (SEA). Unfractionated
spleen cells were irradiated and used as antigen-presenting
stimulators, whereas T cells isolated from spleen were used
as responder cells. Cells from CD18 null and wild-type
mice were of mixed C57BL/6J and 129/Sv background
(both H-2b), whereas cells from BALB/c mice express H-2d.
T cells from wild-type littermates demonstrate a proliferative response to allogeneic stimulation with irradiated
BALB/c cells; no proliferative response was observed with
syngeneic stimulator cells (Fig. 7
A). There was no detectable proliferation of T cells derived from CD18 null mice
with allogeneic or syngeneic stimulator cells (Fig. 7
B). The
T cell response was evaluated further by quantitating the
concentration-dependent proliferative response to SEA.
When T cells from wild-type mice were exposed to SEA,
the maximal [3H]thymidine incorporation ranged from
35,000 to 80,000 cpm at SEA concentrations between 1–10
ng/ml. However, even at an SEA concentration of 10 μg/ml,
[3H]thymidine incorporation was below 10,000 cpm in T
cells derived from CD18 null mice (Fig. 8
A). Stimulation
of cells with phorbol myristate acetate and ionomycin
demonstrated that cells from CD18 null mice were capable
of proliferating normally, if the requirement for the T cell
receptor was bypassed (Fig. 8
B). These data indicate that
CD18 serves a critical role in generating a T cell proliferative response to MHC alloantigens or to SEA.
Figure 7
Abrogation of mixed
lymphocyte reaction in CD18
null mice. Splenocytes from three
wild-type littermate controls (A)
and from three CD18 null mice
(B) were stimulated in a mixed
lymphocyte reaction. Responder
cells (4 × 105 cells per well)
were mixed with increasing concentrations of allogeneic BALB/c
(filled symbols) or with syngeneic
wild-type or CD18 null spleen
cells that had been irradiated
(open symbols). Analysis of proliferation was performed after 96 h
in culture as described in Materials and Methods. Data are presented as mean cpm ± SEM of
triplicate cultures.
Figure 8
Abrogation of T cell
proliferation in response to staphylococcal enterotoxin A (SEA) in
CD18 null mice. In A, splenocytes from three wild-type littermates (filled symbols) and from
CD18 null mice (open symbols)
were cultured without addition
or with 0.1 ng to 20 μg/ml SEA.
In B, splenocytes from wild-type
(filled symbols) or CD18 null (open
symbols) mice were stimulated with
100 ng/ml phorbol myristate acetate and 200 ng/ml ionomycin
and analyzed for proliferation at
the indicated times. Proliferation was quantitated as described
in Materials and Methods and is
expressed as mean cpm ± SEM
of triplicate cultures for three
mice of each genotype.
Discussion
The CD18 null mouse reported here displays a phenotype which is generally similar to that seen for human (4, 7)
and bovine (5, 6) LAD I. The common features include
leukocytosis, spontaneous skin infections, and impaired emigration of neutrophils at sites of infection. Impaired adherence of neutrophils and respiratory burst is similar in CD18
deficient mice and humans. Mutations in humans are heterogeneous, and hypomorphic mutations result in milder
LAD I phenotypes. The hypomorphic mutation in the
mouse is associated with 2–16% of normal levels of CD18
on leukocytes (8) and is analogous to mild or moderate
forms of human LAD I. The hypomorphic mouse mutation may be more appropriate for chronic studies of the
role of CD18 in inflammatory disease processes, while the
null mutation reported here will be more valuable for determining whether CD18 is essential for a particular leukocyte function. Studies with mutant mice complement functional analyses with blocking antibodies most often confirming
but occasionally questioning (28–31) the role of an adhesion molecule in specific leukocyte activities.Mouse mutations in numerous leukocyte and endothelial
cell adhesion molecules have been prepared including leukocyte integrins, immunoglobulin family members (ICAM-1,
VCAM-1), selectins, and selectin ligands (32–35). Mutations in CD11a (10) and CD11b (11, 12) are of particular
interest, since they would affect the subsets of CD18 functions attributable to LFA-1 and Mac-1, respectively. Mice
with CD11a deficiency were found to have a moderate defect in peritoneal emigration at early times, reduced natural
killer cytotoxicity, normal immunoglobulin levels, reduced
responder cell function in MLR, normal CTL responses to
virus, and impaired rejection of tumor cells (10). Mice deficient in CD11b show normal or increased peritoneal emigration, delayed apoptosis of extravasated leukocytes, impaired neutrophil degranulation and binding of neutrophils
to fibrinogen, and reduced neutrophil phagocytosis and oxygen-free radical generation (11, 12).Mice with deficiency of ICAM-1 or individual selectins
are viable and do not develop spontaneous infections under
laboratory conditions, but these mutants show varying abnormalities of leukocyte adhesion, migration, and rolling;
see (32–35) for review and references. Mice with double
deficiency of P-selectin and E-selectin do develop spontaneous cutaneous infections (36, 37), thus sharing some
phenotypic features in common with LAD I. A rare human
disorder affecting fucose metabolism causes leukocyte adhesion deficiency II (LAD II) apparently through an effect
on carbohydrate structure of selectin ligand molecules (38).The increased susceptibility to infection in CD18 null
mice emphasizes the importance of granulocytes and macrophages as an antigen-independent first line of defense in
response to pathogens or tissue injury. There is ample evidence that CD18 is important for the initial emigration of
leukocytes, and it is not surprising that spontaneous cutaneous infections occur in the CD18 null mice, particularly
given the previous information from humans and cattle. A
systemic infectious challenge using intraperitoneal injection
of S. pneumoniae demonstrated the increased infectious susceptibility of the CD18 null mice. These mice had essentially no ability to clear bacteremia and survive the infectious inoculation. Although mice with deficiency of ICAM-1
or individual selectins do not develop spontaneous infections as mentioned above, mice with individual deficiencies
of E-selectin or P-selectin demonstrate increased morbidity
and mortality using the S. pneumoniae inoculation protocol
described here for the CD18 null mice (14). The increased
mortality in CD18 null mice inoculated with S. pneumonia
is not accompanied by a severe defect in neutrophil emigration, since approximately similar numbers of neutrophils
were found in the peritoneal fluid compared with wild-type mice. This CD18-independent emigration is also seen
in CD11b-deficient mice with a thioglycolate-induced
peritonitis (11), and the data from CD18- and CD11b-deficient mice are consistent with the interpretation that neutrophils emigrating by CD18-independent pathways have
different properties, do not function normally, and are not
as effective in eliminating bacteria. Thus, although mice
with individual deficiencies of leukocyte and endothelial
cell adhesion molecules may not develop spontaneous infection under laboratory conditions, deficiency of these
molecules probably causes more subtle susceptibility to infection in almost all cases. It is likely that susceptibility to
infection provides a major pressure for evolutionary conservation of these molecules.The complete deficiency of CD18 leads to severe abnormalities of leukocyte adhesion and activation. These in
vitro abnormalities correlate with severe reductions in the
ability of neutrophils to migrate in to sites of spontaneously
occurring cutaneous infection or in response to toxic dermatitis. The deficiency of CD18 also leads to a substantial
reduction of firm adherence as evaluated by intravital microscopy. However, the in vivo role of CD18 in leukocyte
emigration is extremely complex with the clear existence
of CD18-independent pathways. Using the CD18 null mice
reported here, neutrophil emigration in response to irritant
dermatitis due to croton oil was severely impaired, in
agreement with our results with DNFB-induced dermatitis, but emigration was normal or enhanced during peritonitis induced by either thioglycolate or S. pneumoniae or
with pneumonia induced by S. pneumoniae or E. coli (31).
Although the normal or enhanced emigration of neutrophils in CD18 null mice is somewhat surprising, the data
reported here and those of Mizgard et al. (31) are consistent
with prominent dependence on CD18 for emigration into
soft tissues, variable dependence on CD18 in peritonitis
models, and lesser dependence on CD18 for pulmonary alveolar emigration. There is clear evidence for CD18-
independent pathways of emigration, and perhaps these alternative mechanisms are more readily induced in animals
with severe defects in the function of leukocyte and endothelial cell adhesion molecules as exemplified by the CD18
null mice and P-selectin/E-selectin double mutant mice
(36, 37), both of which develop spontaneous skin disease.The hypothesis has been forwarded that neutrophils initially infiltrating the inflammatory site, via the release of
major T cell and macrophage chemoattractants, set the
stage for the switch in the type of leukocyte infiltration
typically occurring during the evolution of the inflammatory response from acute to chronic stage (39). The CD18
null mice demonstrate that the lack of initiating signals
from egressed neutrophils does not prevent the development of the chronic mononuclear cell infiltrate in spontaneously occurring erosions and toxic dermatitis. However,
cell populations of the chronic infiltrate are not able to prevent the ulcerative dermatitis.A major finding resulting from the analysis of these mice
was the recognition that CD18 deficiency causes a severe
defect in T cell proliferation in response to stimulation of
T cell receptors. Although CD11/CD18 integrins are accepted as playing a costimulatory role in the function of
T cell receptors, their importance is often implied to be less
than for CD28/B7. The defect in the CD18 null mice indicates an essential role for CD11/CD18 integrins in the
response of T cell receptors under the conditions examined. CD18 null T cells fail to proliferate in response to the
potent stimulus of SEA, which typically activates large subfamilies of T cells by interaction with common T cell receptor Vβ elements. Proliferative responses to allogeneic
MHC determinants are similarly abolished. However, elevated serum Ig levels, particularly of certain IgG isotypes
and to a lesser extent IgA, suggest that CD18 null T cell
responses to at least some conventional peptide antigens
occur and provide the cytokine and T cell membrane functions required to achieve B cell growth and isotype
switching.A significant role of the CD11a/CD18(LFA-1) receptor
in SE response has been suggested previously. Antibodies
blocking CD18, CD11a, or ICAM-1 each block SE-induced
T cell growth and cytokine production (40, 41). Additionally, transfected or purified ICAM-1 restores SE-induced T
cell growth under nonpermissive conditions. Other molecules that simply provide adhesion are ineffective, suggesting that distinct costimulatory functions are provided through
LFA-1 binding (42, 43). Naive or resting, rather than
memory T cells are particularly dependent upon LFA-1 costimulation (43). LFA-1 ligation causes increased expression
of the well-recognized CD28/B7 costimulatory molecules
on these cells (44) and may in part account for the role of
CD28 in SE-induced proliferation (45–48). Thus the present
work indicates that CD18+ receptors provide essential early
signaling events in SE responses that are not bypassed by
other costimulator systems of CD18 null T cells.Similarly, antibody blocking and transfection studies
have suggested a predominant role of the CD11a/CD18:
ICAM-1 interaction in T cell responses to allogeneic MHC
molecules (40, 44, 45, 49). Moreover, mice deficient in
CD11a or ICAM-1 exhibit profound depression of MLR
response when used as responder and stimulator populations respectively (10, 50). The present findings indicate
that CD18 similarly plays a critical role in the capacity of T
cells to respond to allogeneic MHC determinants. As in SE
responses, naive alloreactive T cells appear to be critically
dependent upon LFA-1 costimulation (44). In contrast, alloreactive memory T cells can exhibit apoptosis rather than
growth upon coligation of LFA-1 and TCR (51). Thus,
CD18 null T cells activated by bacterial or other antigens
that bypass an initial role of CD18 may manifest dysregulated responses and thereby contribute to elevated cytokine
and Ig production and chronic inflammation.
Authors: R Kirnbauer; A Köck; T Schwarz; A Urbanski; J Krutmann; W Borth; D Damm; G Shipley; J C Ansel; T A Luger Journal: J Immunol Date: 1989-03-15 Impact factor: 5.422
Authors: S J Weisman; R L Berkow; G Plautz; M Torres; W A McGuire; T D Coates; R A Haak; A Floyd; R Jersild; R L Baehner Journal: Blood Date: 1985-03 Impact factor: 22.113
Authors: D C Anderson; F C Schmalsteig; M J Finegold; B J Hughes; R Rothlein; L J Miller; S Kohl; M F Tosi; R L Jacobs; T C Waldrop Journal: J Infect Dis Date: 1985-10 Impact factor: 5.226
Authors: T J Bowen; H D Ochs; L C Altman; T H Price; D E Van Epps; D L Brautigan; R E Rosin; W D Perkins; B M Babior; S J Klebanoff; R J Wedgwood Journal: J Pediatr Date: 1982-12 Impact factor: 4.406
Authors: J P Mizgerd; H Kubo; G J Kutkoski; S D Bhagwan; K Scharffetter-Kochanek; A L Beaudet; C M Doerschuk Journal: J Exp Med Date: 1997-10-20 Impact factor: 14.307
Authors: Tibor Kempf; Alexander Zarbock; Christian Widera; Stefan Butz; Anika Stadtmann; Jan Rossaint; Matteo Bolomini-Vittori; Mortimer Korf-Klingebiel; L Christian Napp; Birte Hansen; Anna Kanwischer; Udo Bavendiek; Gernot Beutel; Martin Hapke; Martin G Sauer; Carlo Laudanna; Nancy Hogg; Dietmar Vestweber; Kai C Wollert Journal: Nat Med Date: 2011-04-24 Impact factor: 53.440
Authors: Jane E Klann; Kelly A Remedios; Stephanie H Kim; Patrick J Metz; Justine Lopez; Lauren A Mack; Ye Zheng; Mark H Ginsberg; Brian G Petrich; John T Chang Journal: J Immunol Date: 2017-05-17 Impact factor: 5.422